X

FDA Approves First Nonprescription Oral Contraceptive

By: Bhojranie Brahmanand, PharmD Candidate c/o 2025 Traditionally, a prescription has always been required for contraceptives such as birth control.…

eMAR

Genetic Variants and its Link to Individuals Asymptomatic to COVID-19

By: Ariella Zadrima, PharmD Candidate c/o 2026 Since coronavirus disease 2019 (COVID-19) first made its appearance in December of 2019,…

eMAR

How drug shortages have affected pharmacies, pharmacists, and patients

By: Jennalynn Fung, PharmD Candidate c/o 2025 Drug shortages are not new; however, their frequency has significantly increased over the…

eMAR

Pharmacy Pearls: How to Identify a Ruptured Brain Aneurysm and Subarachnoid Hemorrhage

By: Maha Sohail, PharmD Candidate c/o 2024 In the United States, about 6.5 million, or 1 in 50 people, have…

eMAR

6th Year Perspective: Meet the President of SCCP

Featuring: Erica Kohen, PharmD Candidate c/o 2024 By: Isabelle Lim, PharmD Candidate c/o 2024 Erica Kohen is a sixth-year pharmacy…

eMAR

Health-Related Mechanisms Behind Exercise

By: Sairah Sheikh, PharmD Candidate c/o 2024 Increased physical activity is often touted as a lifestyle choice that improves bodily…

eMAR

The Current Landscape of Treatment Options for Alzheimer’s Disease

By: Anureet Kaur, PharmD Candidate c/o 2024  Alzheimer’s disease (AD) is an epidemic. Currently, the neurodegenerative disorder holds the title…

eMAR

6th Year Perspective: Guide for Application-Based APPEs

By: Sarah Adly, PharmD Candidate c/o 2024 Applying to advanced professional pharmacy experience (APPE) rotations can be a daunting experience.…

eMAR

It’s in Our Blood: An Exploration of Gene Therapies for Hemophilia A and B

By: Holly Nguyen, PharmD Candidate ℅ 2024 Hemophilia is a severe hereditary hemorrhagic disorder derived from gene mutations that make…

eMAR

Efficacy of Cabozantinib, Nivolumab, and Ipilimumab Combination Therapy in Advanced Clear-Cell Renal-Cell Carcinoma

By: Shakhzoda Rakhimova, PharmD Candidate ℅ 2024 Introduction Renal-cell carcinoma (RCC) is a type of kidney cancer in which malignant…

eMAR